FMR LLC 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-12 10:36 am Sale |
2025-03-31 | 13G | Nurix Therapeutics, Inc. NRIX |
FMR LLC | 10,246,211 13.400% |
-60,140 (-0.58%) |
Filing |
| 2024-12-06 11:34 am Purchase |
2024-11-29 | 13G | Nurix Therapeutics, Inc. NRIX |
FMR LLC | 10,306,351 14.500% |
10,306,351 (New Position) |
Filing |